GenScript Biotech Corporation, a provider of life-science research tools and services, debuted its GenTitan Gene Fragments Synthesis service. The announcement was made at SynBioBeta 2023 in Oakland.

Powered by GenScript’s innovative miniature semiconductor chip (MSC) technology, GenTitan propels gene synthesis to new heights for researchers worldwide, giving scientists from academia and industry access to high-throughput, synthetic DNA for their studies, and accelerating progress in the fields of synthetic biology, protein and antibody engineering, metabolism studies, genomic research, virology, and immunology.

The GenTitan Gene Fragments Synthesis service sets new industry benchmarks in three key areas:

1. Affordability: With a commitment to providing the lowest price on the market, researchers can now cost-effectively leverage the cutting-edge capabilities of GenTitan.
2. High acceptance rate: GenScript confidently accepts challenging sequences, empowering researchers to explore new frontiers without limitations by tackling even the most complex sequences.
3. Low error rate: GenScript is committed to consistently delivering gene fragments with the lowest error rate in the industry to maximize screening efficiency.

“GenScript is thrilled to unveil the GenTitan Gene Fragments Service, a game-changing solution that empowers researchers to expedite gene synthesis at a lower cost,” said Cedric Wu, vice president of GenScript’s Innovation Center. “By leveraging our innovative MSC technology, we are redefining the boundaries of gene synthesis, delivering affordability, accepting challenging sequences from 200 bp to 1,800 bp, and offering the highest level of precision in the industry. GenTitan is a testament to our commitment to advancing biomedical research and enabling scientific breakthroughs.”

According to the company, GenTitan leverages proprietary MSC technology, the industry’s highest-density chip for oligo synthesis, which offers 8.4 million unique electrodes at over 2.5 million per-square-centimeter density. With four chips running in parallel, 6.7 billion base pairs of DNA can be synthesized in just two days, allowing for unprecedented throughput, speed, and accuracy.